XML 104 R85.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information (Depreciation and Amortization by Reportable Segment) (Details) (USD $) In Millions, unless otherwise specified | 12 Months Ended
--- | ---
Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012
Segment Reporting Information |  |  |
Depreciation and amortization | $ 459 | $ 397 | $ 325
Pharmaceutical |  |  |
Segment Reporting Information |  |  |
Depreciation and amortization | 128 | 125 | 114
Medical |  |  |
Segment Reporting Information |  |  |
Depreciation and amortization | 130 | 137 | 119
Corporate |  |  |
Segment Reporting Information |  |  |
Depreciation and amortization | $ 201 | $ 135 | $ 92

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration